Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05077800
Title FOLFIRINOX + 9-Ing-41 + Losartan In Pancreatic Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Colin D. Weekes, M.D.
Indications

pancreatic adenocarcinoma

Therapies

9-ING-41 + Fluorouracil + Irinotecan + Leucovorin + Oxaliplatin

Fluorouracil + Irinotecan + Leucovorin + Losartan + Oxaliplatin

Fluorouracil + Irinotecan + Leucovorin + Oxaliplatin

9-ING-41 + Fluorouracil + Irinotecan + Leucovorin + Losartan + Oxaliplatin

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST